BROMFENAC SODIUM ANHYDROUS
UNII 9X8YF771OU

Substance Identification & Data

This profile provides standardized clinical and technical data for Bromfenac Sodium Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9X8YF771OU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 91714-93-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9X8YF771OU

CAS Registry Number

91714-93-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BROMFENAC SODIUM ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H11BrNO3.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HZFGMQJYAFHESD-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C217757

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23693301

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(C(c2ccc(cc2)Br)=O)c(c(CC([O-])=O)ccc1)N.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bromfenac Sodium Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.